[PubMed] [Google Scholar] 28.Akchurin O.M., Kaskel F
However, despite previous reports on the potential advantage posed by GLP1-based multi-agonists in the management of obesity and metabolic disease, as recently exemplified by the dramatic body weight-lowering actions of the GLP1/GIP dual agonist, tirzepatide 47 , to our knowledge, no study has addressed to date the pharmacological characterization of GLP1-based unimolecular multi-agonists for management of reproductive and metabolic alterations of PCOS, using suitable preclinical models, as pre-requisite for their application in clinics
The human microbiome consists of microorganisms, including bacteria, fungi, viruses, and archaea, that reside within our bodies
Here is how each pathway is supposed to fit together
Compounded tirzepatide belongs to the same class of drugs known as GLP-1 receptor agonists